Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Mild cognitive impairment and dementia.

Albert MS, Blacker D.

Annu Rev Clin Psychol. 2006;2:379-88. Review.

PMID:
17716075
2.

[Mild Cognitive Impairment: potential therapeutics].

Allain H, Bentue-Ferrer D, Belliard S, Reymann JM, Djemaï M, Merienne M.

Rev Neurol (Paris). 2002;158(10 Suppl):S35-40. Review. French.

PMID:
12529584
3.

Mild cognitive impairment: a treatment at last?

Allain H, Bentué-Ferrer D, Akwa Y.

Lancet Neurol. 2004 Nov;3(11):643. Review. No abstract available.

PMID:
15488455
4.

Cracking the therapeutic nut in mild cognitive impairment: better nuts and better nutcrackers.

Knopman DS.

Neurology. 2009 May 5;72(18):1542-3. doi: 10.1212/01.wnl.0000344652.73680.e6. Epub 2009 Jan 28. No abstract available.

PMID:
19176893
5.

Mild cognitive impairment: to treat or not to treat.

Kirshner HS.

Curr Neurol Neurosci Rep. 2005 Nov;5(6):455-7.

PMID:
16263056
6.

Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.

Salloway S, Correia S, Richardson S.

Int Psychogeriatr. 2008 Feb;20(1):40-6. Epub 2007 Jun 28.

PMID:
17597552
7.

Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?

Stiles MM, Martin S, Persons RK.

J Fam Pract. 2006 May;55(5):435-6. Review. No abstract available.

PMID:
16670040
8.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Marder K.

Curr Neurol Neurosci Rep. 2005 Sep;5(5):337-8. No abstract available.

PMID:
16131415
9.

[Alzheimer drugs for mild cognitive impairment].

Fellgiebel A.

Neuropsychiatr. 2007;21(3):230-3. German.

PMID:
17915184
10.

[Dementia].

Sjöbeck M, Nilsson C.

Lakartidningen. 2009 May 13-19;106(20):1369-73. Swedish. No abstract available.

PMID:
19585832
11.

[Mild cognitive impairment: a prodromal phase of dementia?].

Jonker C, Comijs HC.

Tijdschr Gerontol Geriatr. 2007 Jul;38(3):115-21. Review. Dutch.

PMID:
17642317
12.

Clinical trials in mild cognitive impairment: lessons for the future.

Jelic V, Kivipelto M, Winblad B.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):429-38. Epub 2005 Nov 23. Review. Erratum in: J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):892.

13.

Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.

Rozzini L, Costardi D, Chilovi BV, Franzoni S, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2007 Apr;22(4):356-60.

PMID:
17117398
14.

New therapeutic approaches to cognitive impairment.

Schneider LS.

J Clin Psychiatry. 1998;59 Suppl 11:8-13. Review.

15.
16.

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.

Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M.

J Alzheimers Dis. 2013;35(2):349-61. doi: 10.3233/JAD-122140. Review.

PMID:
23411693
17.
18.

Mild cognitive impairment--no benefit from vitamin E, little from donepezil.

Blacker D.

N Engl J Med. 2005 Jun 9;352(23):2439-41. Epub 2005 Apr 13. No abstract available.

PMID:
15829528
19.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
20.

Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.

Small BJ, Gagnon E, Robinson B.

Geriatrics. 2007 Apr;62(4):19-23. Review.

PMID:
17408315

Supplemental Content

Support Center